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Bariatric surgery is efficient treatment of type 2 diabetes mellitus (T2DM). Despite detailed 
qualification, not every patient achieve T2DM remission. Individualised Metabolic Surgery (IMS) and 
DiaRem scores have been recently developed to predict diabetes remission after bariatric surgery. 
Aim:  
To validate and compare the performance of IMS and DiaRem scores as the predictors of diabetes 
remission 1 year after surgical treatment. 
Materials & methods:  
The retrospective analysis included patients with T2DM who underwent Roux-en-Y gastric bypass 
(RYGB) or sleeve gastrectomy (SG) and completed 1-year follow-up. IMS and DiaRem scores were 
calculated for each patient. Each score relationship with diabetes remission was assessed using 
logistic regression. Discrimination was evaluated by area under the receiver operating characteristic 
curve (AUROC) whereas calibration by Hosmer–Lemeshow test. 
Results:  
Out of 252 patients in our study 150 (59.5%) were women whereas 102 (40.5%) were men with 
median age 48 years. 46.83% underwent SG whereas 53.17% had RYGB. The T2DM remission rate 
reached 90.5%. Median of preoperative A1c was 6.75% and preoperative BMI was 45.39 kg/m2, both 
decreased to 5.8% and 33.09 kg/m2 after 1 year. %EWL after surgery was 53.4%.  
Either IMS or DiaRem were predictive of diabetes remission in a logistic regression analysis (OR 0.97; 
p<0.0001; OR 0.83; p<0.0001). Both scores demonstrated acceptable discrimination (AUROC 0.76; 
p<0.0001; AUROC 0.78; p<0.0001). Only DiaRem score presented good calibration. 
Conclusion:  
Both IMS and DiaRem scores can be used in preoperative assessment of bariatric patients, but 
DiaRem score is more accurate than IMS. 
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